Launch of
Download
1 / 26

Launch of IPEC/PQG Excipient GMPs guide Kevin McGlue, Steve Moss - PowerPoint PPT Presentation


  • 115 Views
  • Uploaded on

Launch of IPEC/PQG Excipient GMPs guide Kevin McGlue, Steve Moss. IPEC/PQG Excipient GMPs guide. The organisations Background Key milestones Joint charter (governance and oversight) Development process Major improvements Benefits to Industry and Regulators Implementation Strategy.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Launch of IPEC/PQG Excipient GMPs guide Kevin McGlue, Steve Moss' - neville-stephens


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Launch of ipec pqg excipient gmps guide kevin mcglue steve moss

Launch of

IPEC/PQG Excipient GMPs guide

Kevin McGlue, Steve Moss


Ipec pqg excipient gmps guide
IPEC/PQG Excipient GMPs guide

  • The organisations

  • Background

  • Key milestones

  • Joint charter (governance and oversight)

  • Development process

  • Major improvements

  • Benefits to Industry and Regulators

  • Implementation Strategy


Launch of ipec pqg excipient gmps guide kevin mcglue steve moss
IPEC

  • International Pharmaceutical Excipients Council

  • Formed in 1991 by manufacturers and end-users of excipients

  • Three associations covering the US, Europe and Japan

  • Objective: to contribute to the development and harmonisation of international excipient standards, the introduction of useful new excipients to the marketplace and the development of good manufacturing practice for excipients.

  • First published GMP Guide for Bulk Pharmaceutical Excipients in 1995, revised in 2001 to align with ISO 9001:2000.


Launch of ipec pqg excipient gmps guide kevin mcglue steve moss
PQG

  • Institute of Quality Assurance, Pharmaceutical Quality Group

  • Formed in UK in1977

  • Key objective: To promote the development of a consistent approach to pharmaceutical quality and good manufacturing practice.

  • In 1990 published three codes of practice - pharmaceutical raw materials, printed and contact packaging materials. In 1995 revised and integrated these with ISO 9002:1994.

  • Raw materials code revised and reissued as PS 9100:2002 Pharmaceutical excipients, an application standard and GMP guide for pharmaceutical excipients.


Background to the joint guide
Background to the joint guide

  • Increased focus on Excipient GMPs led to the need for a single international guide

  • June 2002

    • IPEC Europe, IPEC Americas and PQG signed a letter of intent in committing to collaborate on a Baseline GMP guide for excipients

  • December 2002

    • Joint charter issued


Joint charter purpose
Joint Charter – Purpose

  • To produce a joint international GMP guide for excipients, which will build upon and replace the two groups’ existing documents. It will be aligned to ISO 9001:2000 and include a baseline (minimum) GMP for excipients.

  • During development of the document excipients used in more critical applications will be considered for inclusion in Appendices, as appropriate

  • The document will also provide the basis for a certification scheme for excipient suppliers separate from the basic GMP guideline.


Joint charter boundaries
Joint Charter - Boundaries

  • Includes:

    • GMP guide for excipients for all pharmaceutical products

    • GMP guide could be used for certification in subsequent phase

    • Future inclusions include audit and training guides

  • Excludes:

    • Sterile excipients

    • Active Pharmaceutical Ingredients

    • Products of biotechnology

    • Certification process


Joint charter structure
Joint Charter - Structure

  • Steering Committee (Sponsors):

    • 2 Members IPEC-Europe

    • 2 Members IPEC-Americas

    • 2 Members PQG

  • Team Members (Core team):

    • Six members, two from each organisation


Joint charter some stakeholders 1
Joint Charter – Some Stakeholders 1

  • Association of the British Pharmaceutical Industry,

  • CEFIC,

  • Certification bodies for PQG Scheme,

  • European Federation of Pharmaceutical Industry Associations,

  • Excipient suppliers,

  • European Community DG3,

  • European Pharmacopoeia,

  • International Conference on Harmonisation,

  • IPEC-Europe, IPEC-Americas,

  • International Pharmaceutical Excipients Auditing Inc (IPEA),


Joint charter some stakeholders 2
Joint Charter – Some Stakeholders 2

  • Institute of Quality Assurance

  • PQG committee,

  • Pharmaceutical companies,

  • Pharmaceutical Research and Manufacturers of America (PhRMA),

  • Regulatory bodies (Food & Drug Administration, Medicines & Healthcare Products Regulatory Authority etc),

  • United States Pharmacopoeia,

  • World Health Organisation,

  • Japanese Pharmaceutical Excipients Council (JPEC) - as an observer


Key milestones
Key milestones

  • Initial meeting

  • Review process

  • Draft new guide

  • Consultations and review

  • Final review

  • Publication and launch


Initial team meeting
Initial team meeting

23rd January 2003

  • Key principles

  • Project timescales

  • ISO 9001 format

  • Overall document structure

  • Consultation and review process


Initial review process
Initial review process

Started March 2003

  • Reviewed detail of key source documents

    • PQG, IPEC, ISO 9001, ICH Q7a

  • Compared all the clauses in a matrix

  • Chose the most appropriate guidance appropriate for excipients

  • Resolved differences

  • Significant update in line with current thinking

  • Involved careful consideration and deliberation


Drafted new guide
Drafted NEW guide

Q2 2003 to Q1 2004

  • Improved assignment to ISO sections

    • more logical flow and improved readability

  • Key areas improved with significant rewriting include:

    • structure & responsibility of quality unit, product release, validation, stability, change control, GMP principles, auditing considerations

  • “Continuous processing” accounted for throughout

    • E.g. bulk materials, batch documentation and release


Further development of guide
Further development of guide

Q2 to Q3 2004

  • Many multi-day meetings in UK, US, France

  • Continual adaptation to the prevailing changing environment

  • Maintained focus on developing voluntary baseline guidance

    • Potentially with need for additional guidance for specialist applications


Consultation and review
Consultation and review

Q4 2004 to Q3 2005

1. Members comment x2 (some external bodies eg EFPIA via members)

  • Consolidated comments (100’s!) to produce approved draft for external release

    2. External circulation - Key organisations including regulatory authorities, trade organisations and other stakeholders

  • Consolidated comments

    3. Issued to members for final comment

  • Consolidated comments to produce final draft

    4. Comprehensive QC checks x2 teams

  • Corrected to produce draft for printing


Publication printing
Publication & printing

Q4 2005

Hardcopy

  • US English by IPEC Americas

    • letter and pocket versions

  • UK English by IPEC Europe

    • A4 and pocket versions

      Electronic

  • A4/letter downloadable from websites


Launch of ipec pqg excipient gmps guide kevin mcglue steve moss

Thanks to the GMP/Partners groups and the wider membership of each organisation for help and excellent contributions!


Major improvements 1
Major improvements 1 of each organisation for help and excellent contributions!

  • Better assignment to ISO sections to give more logical flow and improved readability

  • Accurate and legible wording

  • Appropriate guidance for excipients

  • Key ‘awkward clauses’ addressed e.g. stability, validation, change control

  • Included continuous processing - particularly the impact on batch definition and records


Major improvements 2
Major improvements 2 of each organisation for help and excellent contributions!

  • Improved auditing considerations - GMP principles and applications

  • Harmonized glossary - rationalised to ICH where possible

  • Consistent use of terminology e.g. document, records; rework, reprocess

  • Removed ambiguity for international use (e.g. recall/retrieval; batch/lot)


Benefits to industry and regulators
Benefits to Industry and Regulators of each organisation for help and excellent contributions!

1. Broadacceptance

  • Document critically reviewed by all stakeholders to obtain consensus

  • Well received by excipients industry and by pharmaceutical companies and their industry bodies, regulators EMEA and EC - suggests balance is appropriate

  • Overall good collaboration between US and Europe resulting in international acceptance


Benefits to industry and regulators1
Benefits to Industry and Regulators of each organisation for help and excellent contributions!

1. Broadacceptance (cont’d)

  • Participation and involvement with many good comments from many members, organisations, etc

  • Working with EC - new guide helping focus discussions and benchmarking appropriate principles which may become law for certain excipients


Benefits to industry and regulators2
Benefits to Industry and Regulators of each organisation for help and excellent contributions!

2. Ease of application

  • Builds additional GMP guidance onto the ISO framework

    • commonly used by the industry already

  • Practical guidance for excipient manufacturer

    • balancing pharmaceutical customers' expectations with usual constraints

  • Clear unambiguous wording


Benefits to industry and regulators3
Benefits to Industry and Regulators of each organisation for help and excellent contributions!

2. Ease of application(cont’d)

  • Provides common guide eliminating the need for multiple customers' requirements.

    • Manufacturer – applies common & appropriate standard, quality systems & controls

    • User – provides common expectation of what is appropriate for excipient manufacturers, audits

  • Clearly differentiates guidance for excipients

    • more than ISO 9001

    • more appropriate than ICH Q7a


Implementation strategy
Implementation Strategy of each organisation for help and excellent contributions!

  • Launch events

    • IPEC Americas – Orlando, 26th January 2006

    • PQG – London, 7th February 2006

    • IPEC Europe – Cannes, 9th February 2006


Additional copies available now
Additional copies available now of each organisation for help and excellent contributions!

  • ipec.org and pqg.org

    • Order forms for printed copies

    • Members download free

  • Please spread the word!